comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 21:35:02 - browse：98417

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Drug repurposing or repositioning? The language matters

WSS

Peter Hotez and the public health issue of online harassment

How to save PrEP access — and even expand it

Dobbs anniversary: the lost opportunity of abortion as health care

How one medical school became remarkably diverse

The debate over Covid

How are insurers handling Leqembi and related scans?

leisure time

comprehensive

Wikipedia

Medicare details structure of new drug price negotiation program

Watch the official trailer for 'Ahsoka' series

In Memoriam: Notable people who died in 2023

One Duchenne patient's bittersweet hope for new treatment

Virginia high school admissions case could be legal follow

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Medicare details structure of new drug price negotiation program

The high cost of giving birth even with insurance

Medicare proposal to cover medical devices draws a mixed reaction

Affirmative action in medical school literally saved lives

explore

One Duchenne patient's bittersweet hope for new treatment

Companies helping big Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

leisure time

explore

focus

leisure time